Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
City of Hope Medical Center
Massachusetts General Hospital
Jonsson Comprehensive Cancer Center
NRG Oncology
University of Southern California